CLINIFER

Cliniphar is a group company that develops B2B e-commerce platforms for the healthcare industry, primarily focusing on pharmaceuticals. The company was established in January 2017 with Kohei Toda as its Representative Director and President. In April 2021, Cliniphar acquired Kosei Pharma Co., Ltd., a company with over 70 years of experience supplying medical and OTC drugs to more than 12,000 clients in Japan, including hospitals, clinics, and pharmacies.

Cliniphar operates two main platforms. For the domestic market, it runs "Kosei Market," an e-commerce platform for medical institutions in Japan offering over 17,000 items. For the international market, it provides "synapse," a database and sales platform for Japanese medical products aimed at pharmaceutical-related companies and medical institutions worldwide. This international business, started in 2018, has expanded to transactions with over 300 companies in 50 countries across Europe, Asia, and the Americas.

The company's business model is centered on facilitating the distribution of pharmaceuticals both within Japan and globally through its digital platforms. It leverages a team knowledgeable in international pharmaceutical regulations and logistics to ensure secure transactions. The group's reported sales were 3.56 billion yen as of March 2025.

Keywords: pharmaceutical e-commerce, medical drug distribution, B2B healthcare platform, Japanese pharmaceuticals, international drug sales, medical supply chain, Kosei Market, synapse platform, healthcare logistics, pharmaceutical export, OTC drugs, prescription medicine, medical trade, Kohei Toda, Kosei Pharma